CHAPIN DAVIS, INC.

Position in TRVI — Trevi Therapeutics, Inc.

CIK 872098 BALTIMORE, MD

Position in TRVI

as of Jun 30, 2026 · filed Jul 7, 2026 Compact

Position Value

$374,865

+$135,072 QoQ

Shares Held

20,100

0.0% QoQ

Ownership

0.014%

of shares outstanding

% of Portfolio

0.08%

of 13F equity value

Holder Rank

of 14 holders

Holding Since

Sep 2025

4 quarters on record

Voting authority Sole 0% Shared 0% None 100%

Healthcare · as of Jun 30, 2026

CHAPIN DAVIS, INC. holds $1,662,100 across 5 Biotechnology names. TRVI ranks #2 (22.6% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	DYAI	Dyadic International Inc	888,004	$799,203
2	TRVI	Trevi Therapeutics, Inc. This page	20,100	$374,865
3	ALNY	Alnylam Pharmaceuticals, Inc.	850	$255,875
4	BEAM	Beam Therapeutics Inc.	6,000	$205,920
5	LCTX	Lineage Cell Therapeutics, Inc.	20,029	$26,237

4 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$374,865	20,100	0.0%	Shares	Sole	2026-07-07
2026-03-31	$239,793	20,100	0.0%	Shares	Sole	2026-04-21
2025-12-31	$251,652	20,100	-42.7%	Shares	Sole	2026-01-30
2025-09-30	$321,165	35,100	—	Shares	Sole	2025-10-09
No filing history on record for this holder in this stock.